Skeletal muscle lipogenic protein expression is not different between lean and obese individuals: A potential factor in ceramide accumulation

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 12, 2009, Pages 5053-5061

  Thrush, A Brianne ^a   Brindley, David N ^b   Chabowski, Adrian ^c   Heigenhauser, George J ^d   Dyck, David J ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A DESATURASE; CERAMIDE; DIACYLGLYCEROL; DIACYLGLYCEROL ACYLTRANSFERASE 1; FATTY ACID; GLYCEROL 3 PHOSPHATE ACYLTRANSFERASE; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN; STEAROYL RETINOL BINDING PROTEIN 1C; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; LEAN BODY WEIGHT; MUSCLE LEVEL; OBESITY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

EID: 73249127400     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-2565     Document Type: Article

References (44)

1. Pan DA, Lillioja S, Kriketos AD, Milner MR, Baur LA, Bogardus C, Jenkins AB, Storlien LH 1997 Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 46:983-988
2. Perseghin G, Scifo P, DeCobelli F, Pagliato E, Battezzati A, Arcelloni C, Vanzulli A, Testolin G, Pozza G, Del Maschio A, Luzi L 1999 Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 48:1600-1606
3. van Loon LJ, Goodpaster BH 2006 Increased intramuscular lipid storage in the insulin-resistant and endurance-trained state. Pflugers Arch 451:606-616
4. Chavez JA, Knotts TA, Wang LP, Li G, Dobrowsky RT, Florant GL, Summers SA 2003 A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. J Biol Chem 278:10297-10303
5. Wang CN, O'Brien L, Brindley DN 1998 Effects of cell-permeable ceramides and tumor necrosis factor-α on insulin signaling and glucose uptake in 3T3-L1 adipocytes. Diabetes 47:24-31
6. Stratford S, Hoehn KL, Liu F, Summers SA 2004 Regulation of insulin action by ceramide: dual mechanisms linking ceramide accumulation to the inhibition of Akt/protein kinase B. J Biol Chem 279:36608-36615
7. Adams 2nd JM, Pratipanawatr T, Berria R, Wang E, DeFronzo RA, Sullards MC, Mandarino LJ 2004 Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Diabetes 53:25-31
8. Straczkowski M, Kowalska I, Baranowski M, Nikolajuk A, Otziomek E, Zabielski P, Adamska A, Blachnio A, Gorski J, Gorska M 2007 Increased skeletal muscle ceramide level in men at risk of developing type 2 diabetes. Diabetologia 50:2366-2373
9. Serlie MJ, Meijer AJ, Groener JE, Duran M, Endert E, Fliers E, Aerts JM, Sauerwein HP 2007 Short-term manipulation of plasma free fatty acids does not change skeletal muscle concentrations of ceramide and glucosylceramide in lean and overweight subjects. J Clin Endocrinol Metab 92:1524-1529
10. Skovbro M, Baranowski M, Skov-Jensen C, Flint A, Dela F, Gorski J, Helge JW 2008 Human skeletal muscle ceramide content is not a major factor in muscle insulin sensitivity. Diabetologia 51:1253-1260
11. Hulver MW, Berggren JR, Cortright RN, Dudek RW, Thompson RP, Pories WJ, MacDonald KG, Cline GW, Shulman GI, Dohm GL, Houmard JA 2003 Skeletal muscle lipid metabolism with obesity. Am J Physiol Endocrinol Metab 284:E741-E747
12. Holloway GP, Thrush AB, Heigenhauser GJ, Tandon NN, Dyck DJ, Bonen A, Spriet LL 2007 Skeletal muscle mitochondrial FAT/CD36 content and palmitate oxidation are not decreased in obese women. Am J Physiol Endocrinol Metab 292:E1782-E1789
13. Bonen A, Parolin ML, Steinberg GR, Calles-Escandon J, Tandon NN, Glatz JF, Luiken JJ, Heigenhauser GJ, Dyck DJ 2004 Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36. FASEB J 18:1144-1146
14. Jamdar SC, Cao WF 1995 Triacylglycerol biosynthetic enzymes in lean and obese Zucker rats. Biochim Biophys Acta 1255:237-243
15. Donkor J, Sariahmetoglu M, Dewald J, Brindley DN, Reue K 2007 Three mammalian lipins act as phosphatidate phosphatases with distinct tissue expression patterns. J Biol Chem 282:3450-3457
16. Phan J, Reue K 2005 Lipin, a lipodystrophy and obesity gene. Cell Metab 1:73-83
17. Liu L, Zhang Y, Chen N, Shi X, Tsang B, Yu YH 2007 Upregulation of myocellular DGAT1 augments triglyceride synthesis in skeletal muscle and protects against fat-induced insulin resistance. J Clin Invest 117:1679-1689
18. Pinnamaneni SK, Southgate RJ, Febbraio MA, Watt MJ 2006 Stearoyl CoA desaturase 1 is elevated in obesity but protects against fatty acid-induced skeletal muscle insulin resistance in vitro. Diabetologia 49:3027-3037
19. Hulver MW, Berggren JR, Carper MJ, Miyazaki M, Ntambi JM, Hoffman EP, Thyfault JP, Stevens R, Dohm GL, Houmard JA, Muoio DM 2005 Elevated stearoyl-CoA desaturase-1 expression in skeletal muscle contributes to abnormal fatty acid partitioning in obese humans. Cell Metab 2:251-261
20. Dobrzyn A, Dobrzyn P, Lee SH, Miyazaki M, Cohen P, Asilmaz E, Hardie DG, Friedman JM, Ntambi JM 2005 Stearoyl-CoA desaturase-1 deficiency reduces ceramide synthesis by downregulating serine palmitoyltransferase and increasing β-oxidation in skeletal muscle. Am J Physiol Endocrinol Metab 288:E599-E607
21. Thrush AB, Heigenhauser GJ, Mullen KL, Wright DC, Dyck DJ 2008 Palmitate acutely induces insulin resistance in isolated muscle from obese but not lean humans. Am J Physiol Regul Integr Comp Physiol 294:R1205-R1212
22. Bruce CR, Thrush AB, Mertz VA, Bezaire V, Chabowski A, Heigenhauser GJ, Dyck DJ 2006 Endurance training in obese humans improves glucose tolerance and mitochondrial fatty acid oxidation and alters muscle lipid content. Am J Physiol Endocrinol Metab 291:E99-E107
23. Manmontri B, Sariahmetoglu M, Donkor J, Bou Khalil M, Sundaram M, Yao Z, Reue K, Lehner R, Brindley DN 2008 Glucocorticoids and cyclic AMP selectively increase hepatic lipin-1 expression, and insulin acts antagonistically. J Lipid Res 49:1056-1067
24. Folch J, Lees M, Sloane Stanley GH 1957 A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226:497-509
25. van der Vusse GJ, Roemen TH, Reneman RS 1980 Assessment of fatty acids in dog left ventricular myocardium. Biochim Biophys Acta 617:347-349
26. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
27. Schenk S, Horowitz JF 2007 Acute exercise increases triglyceride synthesis in skeletal muscle and prevents fatty acid-induced insulin resistance. J Clin Invest 117:1690-1698
28. Lindén D, William-Olsson L, Rhedin M, Asztély AK, Clapham JC, Schreyer S 2004 Overexpression of mitochondrial GPAT in rat hepatocytes leads to decreased fatty acid oxidation and increased glycerolipid biosynthesis. J Lipid Res 45:1279-1288
29. Shimano H, Yahagi N, Amemiya-Kudo M, Hasty AH, Osuga J, Tamura Y, Shionoiri F, Iizuka Y, Ohashi K, Harada K, Gotoda T, Ishibashi S, Yamada N 1999 Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes. J Biol Chem 274:35832-35839
30. Eberlé D, Hegarty B, Bossard P, Ferré P, Foufelle F 2004 SREBP transcription factors: master regulators of lipid homeostasis. Biochimie 86:839-848
31. Sewter C, Berger D, Considine RV, Medina G, Rochford J, Ciaraldi T, Henry R, Dohm L, Flier JS, O'Rahilly S, Vidal-Puig AJ 2002 Human obesity and type 2 diabetes are associated with alterations in SREBP1 isoform expression that are reproduced ex vivo by tumor necrosis factor-α. Diabetes 51:1035-1041
32. Ducluzeau PH, Perretti N, Laville M, Andreelli F, Vega N, Riou JP, Vidal H 2001 Regulation by insulin of gene expression in human skeletal muscle and adipose tissue. Evidence for specific defects in type 2 diabetes. Diabetes 50:1134-1142
33. Itani SI, Ruderman NB, Schmieder F, Boden G 2002 Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IκB-α. Diabetes 51:2005-2011
34. Gaster M, Rustan AC, Beck-Nielsen H 2005 Differential utilization of saturated palmitate and unsaturated oleate: evidence from cultured myotubes. Diabetes 54:648-656
35. Leyton J, Drury PJ, Crawford MA 1987 Differential oxidation of saturated and unsaturated fatty acids in vivo in the rat. Br J Nutr 57:383-393
36. Mei J, Wang CN, O'Brien L, Brindley DN 2003 Cell-permeable ceramides increase basal glucose incorporation into triacylglycerols but decrease the stimulation by insulin in 3T3-L1 adipocytes. Int J Obes Relat Metab Disord 27:31-39
37. Zendzian-Piotrowska M, Baranowski M, Zabielski P, Gorski J 2006 Effects of pioglitazone and high-fat diet on ceramide metabolism in rat skeletal muscles. J Physiol Pharmacol 57(Suppl 10):101-114
38. Peraldi P, Hotamisligil GS, Buurman WA, White MF, Spiegelman BM 1996 Tumor necrosis factor (TNF)-α inhibits insulin signaling through stimulation of the p55 TNF receptor and activation of sphingomyelinase. J Biol Chem 271:13018-13022
39. Meyer SG, de Groot H 2003 Cycloserine and threo-dihydrosphingosine inhibit TNF-α-induced cytotoxicity: evidence for the importance of de novo ceramide synthesis in TNF-α signaling. Biochim Biophys Acta 1643:1-4
40. Saxena S, Banerjee M, Shirumalla RK, Ray A 2008 Ceramide kinase: a potential anti-inflammatory target? Curr Opin Investig Drugs 9:455-462
41. Sathyanarayana P, Barthwal MK, Kundu CN, Lane ME, Bergmann A, Tzivion G, Rana A 2002 Activation of the Drosophila MLK by ceramide reveals TNF-α and ceramide as agonists of mammalian MLK3. Mol Cell 10:1527-1533
42. Hirosumi J, Tuncman G, Chang L, Görgün CZ, Uysal KT, Maeda K, Karin M, Hotamisligil GS 2002 A central role for JNK in obesity and insulin resistance. Nature 420:333-336
43. Vessby B, Gustafsson IB, Tengblad S, Boberg M, Andersson A 2002 Desaturation and elongation of fatty acids and insulin action. Ann NY Acad Sci 967:183-195
44. Borkman M, Storlien LH, Pan DA, Jenkins AB, Chisholm DJ, Campbell LV 1993 The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. N Engl J Med 328:238-244